LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | OSI-027 | 1.11 | uM | LJP6 | 3 | E09 | 72 | hr | 1401 | 1669 | 4223 | 0.3952 | 0.0948 |
| SK-BR-3 | XMD11-85h | 1.11 | uM | LJP6 | 1 | P21 | 72 | hr | 1401 | 3633 | 4223 | 0.8603 | 0.7909 |
| SK-BR-3 | XMD11-85h | 1.11 | uM | LJP6 | 2 | P21 | 72 | hr | 1401 | 3720 | 4223 | 0.8809 | 0.8217 |
| SK-BR-3 | XMD11-85h | 1.11 | uM | LJP6 | 3 | P21 | 72 | hr | 1401 | 3759 | 4223 | 0.8901 | 0.8355 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 1401 | 3033 | 4223 | 0.7182 | 0.5782 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 1401 | 3163 | 4223 | 0.7490 | 0.6243 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 1401 | 3214 | 4223 | 0.7611 | 0.6424 |
| SK-BR-3 | WH-4-025 | 1.11 | uM | LJP5 | 1 | O09 | 72 | hr | 1401 | 4965 | 4223 | 1.1757 | 1.2629 |
| SK-BR-3 | WH-4-025 | 1.11 | uM | LJP5 | 2 | O09 | 72 | hr | 1401 | 4163 | 4223 | 0.9858 | 0.9787 |
| SK-BR-3 | WH-4-025 | 1.11 | uM | LJP5 | 3 | O09 | 72 | hr | 1401 | 4090 | 4223 | 0.9685 | 0.9528 |
| SK-BR-3 | WZ-4-145 | 1.11 | uM | LJP6 | 1 | J21 | 72 | hr | 1401 | 2112 | 4223 | 0.5001 | 0.2518 |
| SK-BR-3 | WZ-4-145 | 1.11 | uM | LJP6 | 2 | J21 | 72 | hr | 1401 | 1852 | 4223 | 0.4385 | 0.1597 |
| SK-BR-3 | WZ-4-145 | 1.11 | uM | LJP6 | 3 | J21 | 72 | hr | 1401 | 2290 | 4223 | 0.5423 | 0.3149 |
| SK-BR-3 | XMD16-144 | 1.11 | uM | LJP5 | 1 | M09 | 72 | hr | 1401 | 1825 | 4223 | 0.4322 | 0.1501 |
| SK-BR-3 | XMD16-144 | 1.11 | uM | LJP5 | 2 | M09 | 72 | hr | 1401 | 1620 | 4223 | 0.3836 | 0.0774 |
| SK-BR-3 | XMD16-144 | 1.11 | uM | LJP5 | 3 | M09 | 72 | hr | 1401 | 1555 | 4223 | 0.3682 | 0.0544 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 1 | P15 | 72 | hr | 1401 | 3846 | 4223 | 0.9107 | 0.8664 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 2 | P15 | 72 | hr | 1401 | 4011 | 4223 | 0.9498 | 0.9248 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 3 | P15 | 72 | hr | 1401 | 4771 | 4223 | 1.1297 | 1.1942 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 1401 | 1289 | 4223 | 0.3052 | -0.0399 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 2 | H03 | 72 | hr | 1401 | 1162 | 4223 | 0.2752 | -0.0849 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 3 | H03 | 72 | hr | 1401 | 1385 | 4223 | 0.3280 | -0.0059 |
| SK-BR-3 | BX-912 | 1.11 | uM | LJP5 | 1 | L21 | 72 | hr | 1401 | 1374 | 4223 | 0.3254 | -0.0098 |
| SK-BR-3 | BX-912 | 1.11 | uM | LJP5 | 2 | L21 | 72 | hr | 1401 | 1492 | 4223 | 0.3533 | 0.0321 |
| SK-BR-3 | BX-912 | 1.11 | uM | LJP5 | 3 | L21 | 72 | hr | 1401 | 1448 | 4223 | 0.3429 | 0.0165 |